ALK B — Alk-Abello A/S Share News
0.000.00%
Last trade - 00:00- DKK51.65bn
- DKK50.34bn
- DKK6.31bn
Brief: Alk-Abello FDA Approves Odactra For Treatment Of House Dust Mite Allergy In Young Children
Brief: ALK-Abello Expects EBIT Margin To Improve To 25% In 2025
Brief: ALK-Abello Q4 Revenue DKK 795 Million
Jefferies ups ALK-Abello on strong launch pipeline
Europe Research Roundup: Admiral, Dowlais Group, Tullow Oil
Alaska Air rises after beating Q4 profit estimates
Brief: ALK-Abello Says Positive Results Advance Peanut Tablet To Phase II Development
Brief: ACARIZAX Approved In Europe For Treatment Of Young Children
Brief: ALK-Abello: Acarizax Approved In Europe For Treatment Of Young Children
Alaska Air shares up after raising Q4 profit forecast
ALK-Abello soars as lower opex drives Q3 EBIT beat
Brief: ALK-Abello 2024 Outlook Remains Unchanged
Brief: ALK-Abello Q3 EBIT Margin 23%
Brief: Alk Says Co Licenses Rights To Neffy
Allergy specialist ALK hits record high after another outlook hike
Brief: ALK-Abello Q2 Revenue DKK 1,374 Million
Brief: ALK-Abello Outlook FY EBIT Margin 19-21%
Europe Research Roundup: Cicor Technologies, Roche Holding, YouGov Plc
ALK-Abello shares rise after another FY outlook hike